- Home
- KOD vs DSM Comparison
KOD vs DSM Comparison
Compare KOD & DSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOD
- DSM
- Stock Information
- Founded
- KOD 2009
- DSM 1989
- Country
- KOD United States
- DSM United States
- Employees
- KOD N/A
- DSM N/A
- Industry
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- DSM Investment Managers
- Sector
- KOD Health Care
- DSM Finance
- Exchange
- KOD Nasdaq
- DSM Nasdaq
- Market Cap
- KOD 259.6M
- DSM 270.9M
- IPO Year
- KOD 2018
- DSM N/A
- Fundamental
- Price
- KOD $3.60
- DSM $5.55
- Analyst Decision
- KOD Hold
- DSM
- Analyst Count
- KOD 3
- DSM 0
- Target Price
- KOD $9.00
- DSM N/A
- AVG Volume (30 Days)
- KOD 419.7K
- DSM 161.7K
- Earning Date
- KOD 05-14-2025
- DSM 01-01-0001
- Dividend Yield
- KOD N/A
- DSM 3.97%
- EPS Growth
- KOD N/A
- DSM N/A
- EPS
- KOD N/A
- DSM N/A
- Revenue
- KOD N/A
- DSM N/A
- Revenue This Year
- KOD N/A
- DSM N/A
- Revenue Next Year
- KOD N/A
- DSM N/A
- P/E Ratio
- KOD N/A
- DSM N/A
- Revenue Growth
- KOD N/A
- DSM N/A
- 52 Week Low
- KOD $1.92
- DSM $4.69
- 52 Week High
- KOD $11.60
- DSM $6.05
- Technical
- Relative Strength Index (RSI)
- KOD 49.07
- DSM 40.81
- Support Level
- KOD $3.46
- DSM $5.55
- Resistance Level
- KOD $3.81
- DSM $5.61
- Average True Range (ATR)
- KOD 0.42
- DSM 0.06
- MACD
- KOD -0.05
- DSM -0.02
- Stochastic Oscillator
- KOD 46.20
- DSM 10.00
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
About DSM BNY Mellon Strategic Municipal Bond Fund Inc.
BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.